No profile data available.
Brainstorm Cell Therapeutics Inc. (BCLI) is a healthcare company in the brain and nerve treatment drugs industry, based in New York, United States, with about 19 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$10.31 million. Its market capitalization was $10.48 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
Brainstorm Cell Therapeutics reported $0 in revenue for fiscal year 2025.
$10.48 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Aeon Biopharma, Inc. (AEON), BioVie Inc. (BIVI), Passage Bio, Inc. (PASG), Vistagen Therapeutics, Inc. (VTGN).